Wave 80 Biosciences Inc - Product Pipeline Analysis, 2018 Update

Summary

Wave 80 Biosciences Inc (Wave 80) is a medical device company that develops molecular diagnostic instruments and consumables. The company develops molecular diagnostics instruments for chlamydia, respiratory illness, cancers, autoimmune diseases, hepatitis B, hepatitis C, HIV/AIDS and other human health conditions. It provides EOSCAPE molecular diagnostics technology that facilitates provision of molecular testing in smaller hospitals and clinics. Wave 80 provides EOSCAPE-HIV, an in vitro nucleic acid assay, which enables the detection and quantitation of human immunodeficiency virus type 1 (HIV-1) RNA. The companys pipeline comprises assays for infectious and non-infectious diseases such as EOSCAPE-HBV DNA, EOSCAPE-HIV RNA PLUS, EOSCAPE-TB, EOSCAPE-TB-DST, and others. It caters to the clinical laboratory testing system markets. Wave 80 is headquartered in San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Wave 80 Biosciences Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


2
List of Tables 3
List of Figures 3
Wave 80 Biosciences Inc Company Overview 4
Wave 80 Biosciences Inc Company Snapshot 4
Wave 80 Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Wave 80 Biosciences Inc Pipeline Analysis Overview 7
Wave 80 Biosciences Inc - Key Facts 7
Wave 80 Biosciences Inc - Major Products and Services 8
Wave 80 Biosciences Inc Pipeline Products by Development Stage 9
Wave 80 Biosciences Inc Pipeline Products Overview 11
Diagnostic Test - Liver Cancer 11
Diagnostic Test - Liver Cancer Product Overview 11
EOSCAPE HIV-1 RNA Viral Load Test 12
EOSCAPE HIV-1 RNA Viral Load Test Product Overview 12
EOSCAPE-HBV DNA 13
EOSCAPE-HBV DNA Product Overview 13
EOSCAPE-HBV DNA PLUS 14
EOSCAPE-HBV DNA PLUS Product Overview 14
EOSCAPE-HCV RNA 15
EOSCAPE-HCV RNA Product Overview 15
EOSCAPE-HIV RNA PLUS 16
EOSCAPE-HIV RNA PLUS Product Overview 16
EOSCAPE-STD 17
EOSCAPE-STD Product Overview 17
EOSCAPE-T1D 18
EOSCAPE-T1D Product Overview 18
EOSCAPE-TB 19
EOSCAPE-TB Product Overview 19
EOSCAPE-TB-DST 20
EOSCAPE-TB-DST Product Overview 20
Integrated Diagnostic System - Influenza A 21
Integrated Diagnostic System - Influenza A Product Overview 21
Wave 80 Biosciences Inc - Key Competitors 22
Wave 80 Biosciences Inc - Key Employees 23
Wave 80 Biosciences Inc - Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
About GlobalData 28
Contact Us 28
Disclaimer 28

List Of Tables


Wave 80 Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Wave 80 Biosciences Inc Pipeline Products by Equipment Type 5
Wave 80 Biosciences Inc Pipeline Products by Indication 6
Wave 80 Biosciences Inc, Key Facts 7
Wave 80 Biosciences Inc, Major Products and Services 8
Wave 80 Biosciences Inc Number of Pipeline Products by Development Stage 9
Wave 80 Biosciences Inc Pipeline Products Summary by Development Stage 10
Diagnostic Test - Liver Cancer - Product Status 11
Diagnostic Test - Liver Cancer - Product Description 11
EOSCAPE HIV-1 RNA Viral Load Test - Product Status 12
EOSCAPE HIV-1 RNA Viral Load Test - Product Description 12
EOSCAPE-HBV DNA - Product Status 13
EOSCAPE-HBV DNA - Product Description 13
EOSCAPE-HBV DNA PLUS - Product Status 14
EOSCAPE-HBV DNA PLUS - Product Description 14
EOSCAPE-HCV RNA - Product Status 15
EOSCAPE-HCV RNA - Product Description 15
EOSCAPE-HIV RNA PLUS - Product Status 16
EOSCAPE-HIV RNA PLUS - Product Description 16
EOSCAPE-STD - Product Status 17
EOSCAPE-STD - Product Description 17
EOSCAPE-T1D - Product Status 18
EOSCAPE-T1D - Product Description 18
EOSCAPE-TB - Product Status 19
EOSCAPE-TB - Product Description 19
EOSCAPE-TB-DST - Product Status 20
EOSCAPE-TB-DST - Product Description 20
Integrated Diagnostic System - Influenza A - Product Status 21
Integrated Diagnostic System - Influenza A - Product Description 21
Wave 80 Biosciences Inc, Key Employees 23
Glossary 27

List Of Figures


Wave 80 Biosciences Inc Pipeline Products by Equipment Type 5
Wave 80 Biosciences Inc Pipeline Products by Development Stage 9

Global Lithotripsy Devices Market Size Study By Type (Intracorporeal, and Extracorporeal Shock Wave), By Application (Pancreatic Stones, Kidney Stones, Bile Duct Stones, and Ureteral Stones), By End-User (Ambulatory Surgical Centers, Hospitals, and Others), and By Regional Forecasts, 2018-2025

Global Lithotripsy Devices Market to reach USD 2.03 billion by 2025.Global Lithotripsy Devices Market valued approximately USD 1.28 billion in 2016 is forecasted to grow with a healthy growth rate

USD 3150 View Report

Wave 80 Biosciences Inc - Product Pipeline Analysis, 2018 Update

Wave 80 Biosciences Inc (Wave 80) is a medical device company that develops molecular diagnostic instruments and consumables. The company develops molecular diagnostics instruments for chlamydia, respiratory illness, cancers, autoimmune

USD 750 View Report

Wave 80 Biosciences Inc - Product Pipeline Analysis, 2017 Update

Wave 80 Biosciences Inc (Wave 80) is a medical device company that develops molecular diagnostic instruments and consumables. The company develops molecular diagnostics instruments for chlamydia, respiratory illness, cancers, autoimmune

USD 750 View Report

Wave 80 Biosciences Inc. Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Wave 80 Biosciences Inc. Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available